Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin’s lymphoma

Por A Boland, A Bagust, J Hockenhull, H Davis, P Chu, R Dickson
Publicado em 2009-09-01

Systematic review and cost-effectiveness evaluation of ‘pill-in-the-pocket’ strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous ant...

Por C Martin Saborido, J Hockenhull, A Bagust, A Boland, R Dickson, D Todd
Publicado em 2010-06-01

Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Por T Brown, A Boland, A Bagust, J Oyee, J Hockenhull, Y Dundar, R Dickson, VS Ramani, C Proudlove
Publicado em 2010-10-01

Rituximab for the treatment of rheumatoid arthritis

Por A Bagust, A Boland, J Hockenhull, N Fleeman, J Greenhalgh, Y Dundar, C Proudlove, T Kennedy, R Moots, P Williamson, R Dickson
Publicado em 2009-09-01

A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

Por J Hockenhull, M Elremeli, MG Cherry, J Mahon, M Lai, J Darroch, J Oyee, A Boland, R Dickson, Y Dundar, R Boyle
Publicado em 2012-03-01

Erlotinib for the treatment of relapsed non-small cell lung cancer

Por C McLeod, A Bagust, A Boland, J Hockenhull, Y Dundar, C Proudlove, H Davis, J Green, F Macbeth, J Stevenson, T Walley, R Dickson
Publicado em 2009-06-01